Novel Aldosterone Synthase Inhibitor Lorundrostat Shows Promise for Uncontrolled Hypertension in CKD
A new aldosterone synthase inhibitor added to SGLT2 inhibitors reduces uncontrolled blood pressure in patients with chronic kidney disease, according to the results of a phase 2 trial.
Acetylation of lysine residues in the tail domain of histone H3 is well characterized, but lysine residues in the histone globular domain are also acetylated. Histone modifications in globular domain ...
FROM 27th September–1st October 2025, Amsterdam, the Netherlands, welcomed over 22,000 respiratory professionals to the ...
TipRanks on MSN
Up Triple Digits: Can These 2 ‘Monster Growth’ Stocks Break into New Highs? Analysts Weigh In
Growth stocks never fail to capture investors’ attention, and for good reason. When a stock doubles in just a few months, it’s clear that ...
Derry Journal on MSN
Yellow weather warning issued for Derry before cold spell arrives later this week
Met Éireann has issued a yellow rain warning for Cork, Kerry, Carlow, Kilkenny, Wexford, Wicklow, Tipperary and Waterford but ...
SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider ...
Covering 100 MHz to 1 GHz, the compact device delivers higher gain, lower power consumption, and wideband flexibility, eliminating the need for multiple region-specific amplifiers while boosting ...
The anguish isn't over lost memories, but losing the people we love while still alive. The cruelest Alzheimer's symptom is ...
Environmentalists are at it again, this time claiming that AI centers will create environmental disasters all over the country. Once again, they exaggerate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback